Venous thromboembolism – or VTE – is often more commonly described to patients as a condition in which blood clots form deep in the veins of a person’s leg, arm, or groin. These clots can sometimes travel to other parts of the body, like the lungs, causing serious and sometimes fatal complications.

Now, 22 new genetic variants are being linked to VTE, as published in a recent study from researchers working at Massachusetts General Hospital (MGH), the Broad Institute of MIT and Harvard, and the U.S. Department of Veterans Affairs (VA) Boston Healthcare System.

The study, published in this month’s issue of Nature Genetics, also details the investigators’ work to come up with a genetic risk score for VTE, which could one day help doctors predict those patients most vulnerable to developing the condition.

Read the full story.